Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02546713 · ClinicalTrials.gov registry record · NA
Abutment Macro Design and Peri-implant Tissues
A NA study of Edentulous, sponsored by Nova Southeastern University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT02546713: Completed NA study of Edentulous, sponsored by Nova Southeastern University.
NCT02546713 is a NA study of Edentulous that has completed, run by Nova Southeastern University. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02546713, a NA study of Edentulous, has completed, sponsored by Nova Southeastern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the maxillary premolar region.
Primary Outcome
The primary outcome variable will be change on peri-implant mucosa margin position.
Conditions Studied
Interventions
- OTHER Abutment with concave subcritical contour
- OTHER Abutment with convex subcritical contour
Study Locations (1)
Florida
- Nova Southeastern University - Fort Lauderdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-12 |
| Est. Completion | 2021-11-30 |
| Phase | NA |
What the finished NCT02546713 record still lists
NCT02546713 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Edentulous appearing as the primary indexed condition, and to 2 interventions - of which Abutment with concave subcritical contour is the first listed.
NCT02546713 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT02546713 about?
NCT02546713 is a clinical study titled "Abutment Macro Design and Peri-implant Tissues". The aim of this study is to evaluate the effect of abutment macro-design on soft and hard tissue responses. This trial is designed as a randomized controlled clinical study in which two groups of fourteen partially edentulous patients will have as part of their treatment one implant placed in the ma...
What is the current status of trial NCT02546713?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-12. Estimated completion is 2021-11-30.
What conditions does trial NCT02546713 study?
This clinical trial studies the following conditions: Edentulous.
What interventions are being tested in trial NCT02546713?
The interventions under investigation include: Abutment with concave subcritical contour (OTHER), Abutment with convex subcritical contour (OTHER).
Who is sponsoring clinical trial NCT02546713?
This trial is sponsored by Nova Southeastern University, which has 71 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02546713 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02546713's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia